Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Clinical trial NCT01250470 · COMPLETED

Trial details

NCT number: NCT01250470
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anaplastic Astrocytoma Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Giant Cell Glioblastoma Glioblastoma Gliosarcoma Mixed Glioma Recurrent Brain Neoplasm

Start date: 2012-09-05
Primary completion: 2014-05-29
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.